Indications for Surgical Intervention Mitral Regurgitation and Aortic

  • Slides: 9
Download presentation
Indications for Surgical Intervention —Mitral Regurgitation and Aortic Insufficiency Ryan Hampton OMS IV January

Indications for Surgical Intervention —Mitral Regurgitation and Aortic Insufficiency Ryan Hampton OMS IV January 2015

Mitral Regurgitation—Indications for Valve Replacement �Considerations • • • Is MR severe? Is patient

Mitral Regurgitation—Indications for Valve Replacement �Considerations • • • Is MR severe? Is patient symptomatic? Is patient a good candidate? What is Left Ventricular function? Will mitral valve repair improve quality of life and mortality?

Mitral Regurgitation—Indications for Valve Replacement �Severe Chronic Primary MR AND • Symptomatic with LVEF>60%

Mitral Regurgitation—Indications for Valve Replacement �Severe Chronic Primary MR AND • Symptomatic with LVEF>60% • LVEF between 30 -60% irrespective of symptoms • LVEF <30% only in the event of a primary mitral apparatus defect �Not strong evidence for surgery in LVEF<30% in the event that MR is secondary to LV dysfunction • No significant symptomatic or mortality benefit

Mitral Regurgitation—Indications for Valve Replacement (ref: 2006 ACC/AHA and 2012 Euro Soc Cardiology) �

Mitral Regurgitation—Indications for Valve Replacement (ref: 2006 ACC/AHA and 2012 Euro Soc Cardiology) � Severe Chronic Primary MR Characteristics (in order of significance) • • • Defined by doppler echocardiography Vena contracta width >/= 7 mm Regurgitant orifice >0. 40 cm 2 Regurgitant volume >/= 60 Regurgitant fraction >/= 50% Jet area > 40% of left atrial area � Almost always need left atrial or left ventricular enlargement for dx of severe MR (LVEDd >60 mm)

Mitral Regurgitation—The Asymptomatic Patient �In the absence of symptoms, management decisions are based on

Mitral Regurgitation—The Asymptomatic Patient �In the absence of symptoms, management decisions are based on echo and LV function �If Severe chronic MR is identified in presence of Normal LV function (EF>60%), patients should be evaluated every 6 -12 months with repeat echo with decision for surgery deferred until symptoms present or LV function is compromised

Mitral Regurgitation—LV Dysfunciton �If patient has severely impaired left ventricular function (LVEF<30%), MV repair

Mitral Regurgitation—LV Dysfunciton �If patient has severely impaired left ventricular function (LVEF<30%), MV repair often does not alter long-term mortality or need for pacemaker �ACC/AHA Guidelines • Surgery if: severe MR in presence of LV dysfunction is due to primary mitral apparatus abnormality (not functional MR) causing LV impairment

Mitral Regurgitation—Indications for Valve Replacement (ref: 2006 ACC/AHA and 2012 Euro Soc Cardiology) �Severe

Mitral Regurgitation—Indications for Valve Replacement (ref: 2006 ACC/AHA and 2012 Euro Soc Cardiology) �Severe Chronic Primary MR—Factors determining timing of surgery • • • Severity Symptoms LV function Valve repair feasibility Presence of AF, Pulmonary HTN Patient preference/expectation

Aortic Regurgitation—Indications for Valve Replacement—Class I Evidence � Severe Chronic AR AND: • Symptomatic

Aortic Regurgitation—Indications for Valve Replacement—Class I Evidence � Severe Chronic AR AND: • Symptomatic • Asymptomatic with LVEF<50% at rest • Asymptomatic, LVEF>50% at rest with LVESd>55 mm or LVEDd>75 mm (and sometimes considered with lower thresholds) • s/p CABG or other valvular or aorta surgery � NOT recommended in asymptomatic patient with LVEF>50% without severe LV dilatation • Periodic echocardiographic monitoring is reasonable

Aortic Regurgitation—Indications for Valve Replacement Waiting for patient to develop exercise intolerance/dysnea may result

Aortic Regurgitation—Indications for Valve Replacement Waiting for patient to develop exercise intolerance/dysnea may result in some irreversible LV dysfunction � There, valve replacement for AR in asymptomatic patient with chronic severe AR with LVEF<50% is recommended �